SCHEMBL349529

SCHEMBL349529

c1ccc(Nc2ccc(-c3ccc(Nc4ccccc4)cc3-c3cccc4ccccc34)c(-c3cccc4ccccc34)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
HSD17B10 Q99714 4/20 0.52
CYP3A4 P08684 4/20 0.52
HPGD P15428 3/20 0.52
MAPT P10636 6/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
TSHR P16473 3/20 0.50
ALOX15 P16050 2/20 0.50
TP53 P04637 1/20 0.50
CDC25B P30305 1/20 0.50
ATM Q13315 1/20 0.50
AR P10275 1/20 0.50
KDM4E B2RXH2 3/20 0.48
RAB9A P51151 1/20 0.48
APP P05067 1/20 0.45
TDP1 Q9NUW8 3/20 0.45
MAPK1 P28482 2/20 0.45
ALOX12 P18054 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL143109 0.92 ALDH1A1 (0.47) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL29362993 0.92 ALDH1A1 (0.47) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL25568766 0.92 ALDH1A1 (0.47) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL29597199 0.87 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL27012227 0.87 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL24552434 0.87 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL24911408 0.87 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL25568946 0.87 ALDH1A1 (0.48) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL23561266 0.87 ALDH1A1 (0.54) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL7758308 0.85 ALDH1A1 (0.49) ALDH1A1HSD17B10CYP3A4HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019195383-A1 ORGANIC LIGHT EMITTING DIODES AND METHODS OF USE THEREOF NORTH CAROLINA STATE UNIVERSITY (US) 2019-10-10 WO claimed
EP-2202821-B1 Organic light emitting apparatus and method of manufacturing the same SAMSUNG DISPLAY CO LTD (KR) 2019-04-10 EP claimed
WO-2012021968-A1 ORGANIC/INORGANIC HYBRID OPTICAL AMPLIFIER WITH WAVELENGTH CONVERSION BAN DAYAN (CA) 2012-02-23 WO claimed
EP-1712109-A4 FLEXIBLE ELECTROLUMINESCENT DEVICES AGENCY SCIENCE TECH & RES (SG) 2008-03-19 EP claimed
EP-1712109-A1 FLEXIBLE ELECTROLUMINESCENT DEVICES Agency for Science, Technology and Research (SG) 2006-10-18 EP claimed
WO-2005064993-A1 FLEXIBLE ELECTROLUMINESCENT DEVICES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2005-07-14 WO claimed
US-20020146590-A1 Organic electroluminescent material and device made therefrom NIPPON STEEL CHEMICAL CO., LTD. (JP) 2002-10-10 US claimed
US-12630576-B2 Light-emitting device including organometallic compound, electronic apparatus including the light-emitting device, and the organometallic compound SAMSUNG DISPLAY CO., LTD. (KR) 2026-05-19 US disclosed
US-12588354-B2 Light-emitting device including fused cyclic compound, electronic apparatus including the light-emitting device, and the fused cyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2026-03-24 US disclosed
US-12577457-B2 Nanoparticle ink composition, light-emitting device, and method of manufacturing the light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2026-03-17 US disclosed
US-12570630-B2 Heterocylic compound and light-emitting device and electronic apparatus including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2026-03-10 US disclosed
US-12545835-B2 Light-emitting device including heterocyclic compound and electronic apparatus including the light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2026-02-10 US disclosed
US-12509627-B2 Nano composite, a nanoparticle ink composition including same, and a light-emitting device including the nanoparticle ink composition SAMSUNG DISPLAY CO., LTD. (KR) 2025-12-30 US disclosed
US-20030104243-A1 Green organic light emitting devices XEROX CORPORATION 2003-06-05 US disclosed
US-20030104242-A1 Tertiary aromatic amine (tetraarylbenzidine), metal oxinoid, (8-hydroxyquinoline aluminum); and red emitting nitrogen heterocycle metal coordination compound, (octaethyl-21H, 23H-porphine platinum) XEROX CORPORATION 2003-06-05 US disclosed
EP-1311009-A2 Organic light emitting devices Xerox Corporation (US) 2003-05-14 EP disclosed
EP-1311139-A1 Green organic light emitting devices Xerox Corporation (US) 2003-05-14 EP disclosed
EP-1311141-A1 Red organic light emitting devices Xerox Corporation (US) 2003-05-14 EP disclosed
US-20030087125-A1 Organic light emitting devices XEROX CORPORATION 2003-05-08 US disclosed
WO-2003018712-A1 ORGANIC LUMINESCENT COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME NEOVIEW CO., LTD. (KR) 2003-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020146590-A1 Organic electroluminescent material and device made therefrom NR4A3, NR4A2, TIMM44 ALDH1A1 838/4885HSD17B10 3058/4885CYP3A4 1994/4885
US-12509627-B2 Nano composite, a nanoparticle ink composition including same, and a light-emitting device including the nanoparticle ink composition NAP1L1, NAP1L4, NOXO1 ALDH1A1 1886/4885HSD17B10 3881/4885CYP3A4 2691/4885
US-12570630-B2 Heterocylic compound and light-emitting device and electronic apparatus including the heterocyclic compound CRY1, NR3C1, AR ALDH1A1 460/4885HSD17B10 977/4885CYP3A4 341/4885
US-12588354-B2 Light-emitting device including fused cyclic compound, electronic apparatus including the light-emitting device, and the fused cyclic compound CRY1, SCO2, RER1 ALDH1A1 1115/4885HSD17B10 1375/4885CYP3A4 557/4885
US-12577457-B2 Nanoparticle ink composition, light-emitting device, and method of manufacturing the light-emitting device JAK1, MYH9, MEF2D ALDH1A1 241/4885HSD17B10 2981/4885CYP3A4 2252/4885
US-12630576-B2 Light-emitting device including organometallic compound, electronic apparatus including the light-emitting device, and the organometallic compound ZC3HAV1L, SOD1, GPS1 ALDH1A1 1718/4885HSD17B10 4214/4885CYP3A4 2716/4885
US-12545835-B2 Light-emitting device including heterocyclic compound and electronic apparatus including the light-emitting device CCNE2, SCO2, CCNT1 ALDH1A1 806/4885HSD17B10 2134/4885CYP3A4 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.